VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,359,951 | -59.5% | 1,648,456 | -54.7% | 0.01% | -57.1% |
| Q2 2023 | $109,459,816 | +29.3% | 3,635,331 | +39.0% | 0.02% | +23.5% |
| Q1 2023 | $84,624,171 | -36.0% | 2,615,894 | -43.3% | 0.02% | -34.6% |
| Q4 2022 | $132,154,154 | +119.3% | 4,611,101 | +84.6% | 0.03% | +100.0% |
| Q3 2022 | $60,250,000 | +150.2% | 2,497,925 | +184.0% | 0.01% | +160.0% |
| Q2 2022 | $24,084,000 | -68.0% | 879,615 | -55.2% | 0.01% | -61.5% |
| Q1 2022 | $75,370,000 | +163.6% | 1,965,337 | +120.2% | 0.01% | +160.0% |
| Q4 2021 | $28,590,000 | +154.3% | 892,611 | +134.0% | 0.01% | +150.0% |
| Q3 2021 | $11,241,000 | -59.9% | 381,428 | -53.7% | 0.00% | -60.0% |
| Q2 2021 | $28,001,000 | +17.8% | 824,028 | +12.7% | 0.01% | +25.0% |
| Q1 2021 | $23,760,000 | -50.8% | 731,067 | -45.5% | 0.00% | -55.6% |
| Q4 2020 | $48,290,000 | -50.1% | 1,340,631 | -45.8% | 0.01% | -55.0% |
| Q3 2020 | $96,815,000 | +15.8% | 2,472,311 | +8.4% | 0.02% | +5.3% |
| Q2 2020 | $83,618,000 | +155.3% | 2,279,680 | +60.4% | 0.02% | +111.1% |
| Q1 2020 | $32,749,000 | -45.7% | 1,421,418 | -30.9% | 0.01% | -30.8% |
| Q4 2019 | $60,270,000 | +263.4% | 2,058,400 | +231.5% | 0.01% | +225.0% |
| Q3 2019 | $16,587,000 | +326.0% | 620,999 | +307.6% | 0.00% | +300.0% |
| Q2 2019 | $3,894,000 | +5.0% | 152,356 | -7.9% | 0.00% | 0.0% |
| Q1 2019 | $3,708,000 | -96.6% | 165,356 | -96.8% | 0.00% | -96.4% |
| Q4 2018 | $109,921,000 | +7.7% | 5,211,963 | -5.4% | 0.03% | +33.3% |
| Q3 2018 | $102,032,000 | +395.6% | 5,509,332 | +497.0% | 0.02% | +320.0% |
| Q2 2018 | $20,587,000 | +873.4% | 922,797 | +859.0% | 0.01% | – |
| Q1 2018 | $2,115,000 | -95.6% | 96,223 | -95.4% | 0.00% | -100.0% |
| Q4 2017 | $48,143,000 | +40.4% | 2,071,578 | +38.7% | 0.01% | +37.5% |
| Q3 2017 | $34,301,000 | -0.9% | 1,493,955 | -4.7% | 0.01% | 0.0% |
| Q2 2017 | $34,601,000 | -2.7% | 1,567,089 | +0.5% | 0.01% | -11.1% |
| Q1 2017 | $35,574,000 | +811.5% | 1,559,589 | +735.8% | 0.01% | +800.0% |
| Q4 2016 | $3,903,000 | -6.3% | 186,589 | +18.4% | 0.00% | 0.0% |
| Q3 2016 | $4,166,000 | -77.2% | 157,613 | -76.1% | 0.00% | -80.0% |
| Q2 2016 | $18,268,000 | – | 659,512 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |